HUP0000316A2 - Exodus chemokine materials and methods - Google Patents

Exodus chemokine materials and methods

Info

Publication number
HUP0000316A2
HUP0000316A2 HU0000316A HUP0000316A HUP0000316A2 HU P0000316 A2 HUP0000316 A2 HU P0000316A2 HU 0000316 A HU0000316 A HU 0000316A HU P0000316 A HUP0000316 A HU P0000316A HU P0000316 A2 HUP0000316 A2 HU P0000316A2
Authority
HU
Hungary
Prior art keywords
materials
methods
exodus
chemokine
exodus chemokine
Prior art date
Application number
HU0000316A
Other languages
English (en)
Inventor
Robert Hromas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HUP0000316A2 publication Critical patent/HUP0000316A2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/521Chemokines
    • C07K14/523Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HU0000316A 1996-11-15 1997-11-14 Exodus chemokine materials and methods HUP0000316A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74951396A 1996-11-15 1996-11-15

Publications (1)

Publication Number Publication Date
HUP0000316A2 true HUP0000316A2 (en) 2000-07-28

Family

ID=25014053

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0000316A HUP0000316A2 (en) 1996-11-15 1997-11-14 Exodus chemokine materials and methods

Country Status (14)

Country Link
US (1) US6096300A (hu)
EP (1) EP0894134A1 (hu)
JP (1) JP2001516203A (hu)
CN (1) CN1213401A (hu)
AU (1) AU5255398A (hu)
BR (1) BR9707142A (hu)
CA (1) CA2242384A1 (hu)
CZ (1) CZ220298A3 (hu)
HU (1) HUP0000316A2 (hu)
IL (1) IL125351A0 (hu)
NO (1) NO983238L (hu)
PL (1) PL327853A1 (hu)
SK (1) SK96398A3 (hu)
WO (1) WO1998021330A1 (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391589B1 (en) 1994-08-23 2002-05-21 Human Genome Sciences, Inc. Human chemokine beta-10 mutant polypeptides
US6174995B1 (en) 1994-08-23 2001-01-16 Haodong Li Human chemokines, CKβ4 and CKβ10/MCP-4
US6458349B1 (en) 1995-06-02 2002-10-01 Human Genome Sciences, Inc. Chemokine β-4 polypeptides
EP0979282A1 (en) * 1997-04-30 2000-02-16 F. Hoffmann-La Roche Ag Rat st38.2 chemokine
US20030144225A1 (en) * 2001-12-28 2003-07-31 Karras James G. Antisense modulation of macrophage inflammatory protein 3-alpha expression
AU6497799A (en) * 1998-10-15 2000-05-01 Canji, Inc. Methods and compositions to induce antitumor response
US6649158B1 (en) 1998-10-15 2003-11-18 Canji, Inc. Methods and compositions to induce antitumor response
WO2002032927A2 (en) * 2000-10-19 2002-04-25 Genaissance Pharmaceuticals, Inc. Haplotypes of the scya20 gene
ATE518884T1 (de) * 2002-05-01 2011-08-15 Human Genome Sciences Inc Spezifisch an chemokin beta-4 bindende antikörper
US8034831B2 (en) 2002-11-06 2011-10-11 Celgene Corporation Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies
US7563810B2 (en) 2002-11-06 2009-07-21 Celgene Corporation Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases
AR084141A1 (es) 2010-11-19 2013-04-24 Imai Toshio Anticuerpos neutralizadores anti-ccl20

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037630A (en) * 1985-01-14 1991-08-06 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US4965392A (en) * 1987-03-26 1990-10-23 Neorx Corporation Chelating compounds for metal-radionuclide labeled proteins
US5179078A (en) * 1989-05-12 1993-01-12 Dana Farber Cancer Institute Method of suppressing tumor formation in vivo
US5413778A (en) * 1992-10-05 1995-05-09 The Regents Of The University Of Michigan Labelled monocyte chemoattractant protein material and medical uses thereof
KR970705405A (ko) * 1994-08-23 1997-10-09 벤슨 로버트 에이취 사람 케모킨 폴리펩타이드(Human Chemokine Polypeptides)
US5602008A (en) * 1994-11-29 1997-02-11 Incyte Pharmaceuticals, Inc. DNA encoding a liver expressed chemokine
EP0909321A2 (en) * 1996-07-05 1999-04-21 Schering Corporation Mammalian chemokine reagents

Also Published As

Publication number Publication date
US6096300A (en) 2000-08-01
EP0894134A1 (en) 1999-02-03
JP2001516203A (ja) 2001-09-25
NO983238L (no) 1998-09-15
NO983238D0 (no) 1998-07-14
IL125351A0 (en) 1999-03-12
CN1213401A (zh) 1999-04-07
WO1998021330A1 (en) 1998-05-22
BR9707142A (pt) 1999-12-28
AU5255398A (en) 1998-06-03
SK96398A3 (en) 1999-04-13
CA2242384A1 (en) 1998-05-22
PL327853A1 (en) 1999-01-04
CZ220298A3 (cs) 1999-01-13

Similar Documents

Publication Publication Date Title
GB9620390D0 (en) Substances and their uses
EP1021185A4 (en) DIHYDROPYRIMIDINE AND ITS USES.
ZA9711141B (en) Novel ketobenzamides and their use
HUP0001020A3 (en) Stanol composition and the use thereof
PL333407A1 (en) Multipurpose absorptive material and articles made thereof
EP0894807A4 (en) GPIb lipid complex and its applications
GB9625899D0 (en) Substances and their uses
HUP9700446A3 (en) Oilsuspension-concentrate and using thereof
PL329351A1 (en) Piperidines and pyrolydines
AU5383498A (en) Human chemokine beta-13
HUP0000316A2 (en) Exodus chemokine materials and methods
PL332631A1 (en) Spray-crystallised products and associated methods
AU7419396A (en) Clothespin and clothes-equipment
IL127568A0 (en) Chitinase materials and methods
HK1025625A1 (en) Barrier unit and articles made therefrom
PL331523A1 (en) Azolotrizines and azolopyrimidines
GB9623539D0 (en) Enzymes and their use
GB2288092B (en) Sample and hold arrangement
HUP9900068A3 (en) Fuse-switch and/or fuse-disconnector
GB9616563D0 (en) Compounds and methods
EP0904398A4 (en) CHEMOKINE ALPHA 3
EP0934345A4 (en) CONNECTIONS AND PROCEDURE
GB9618423D0 (en) Structure and device
IL127551A0 (en) Chemokine beta-15
SG52943A1 (en) Improved construction products and methods